CoreRx, Inc. (“CoreRx”) announces that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics. CoreRx’s tender offer to acquire all of the issued and outstanding shares of common stock (the “Shares”) of Societal CDMO, at a purchase price of $1.10 per Share, in cash, without interest and less any applicable tax withholding, expired as scheduled one minute following 11:59 p.m., Eastern Time, on April 5, 2024 and was not further extended.
Read the full article: CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc. //
Source: https://www.businesswire.com/news/home/20240408651990/en/CoreRx-Inc.-Completes-Acquisition-of-Societal-CDMO-Inc.